Company Updates

PERTH, AUSTRALIA: 19 July 2013: Leading Australian peptide drug discovery company Phylogica Limited (ASX:PYC, XETRA:PH7) has appointed Dr Richard Hopkins as the company’s new Chief Executive Officer as part of a broad company strategic review. He will be appointed to the Board effective immediately. Dr Hopkins has been with Phylogica since 2006, where he has […]

19 July 2013, Sydney, Australia: Viralytics Limited (ASX:VLA, OTC:VRACY) today announced strong interim results from its Phase 2 clinical trial of CAVATAK™ treatment in late stage melanoma patients. The interim data shows solid progress towards achieving the primary endpoint of the study and stregthens the evidence of the tolerability of  CAVATAK™ in late stage melanoma patients. Earlier […]

Sydney, 16th July 2013 Rampart Energy Ltd (ASX:RTD) is an emerging petroleum explorer who has managed to complete the impossible over the last 6 months , acquire an asset which could be worth hundreds of millions of dollars in the backyard of Super-major oil companies while having a market cap of ~$4 million dollars. Rampart […]

Indoor Skydive Australia Group (ASX:IDZ) are pleased to advise that construction is proceeding according to plan on the first commercial indoor skydiving facility at Penrith, with the excavation complete after no adverse underground findings. The next steps in construction include the delivery and introduction of 50 tonnes of steel reinforcement into the basement of the […]

MEDIA STATEMENT 12 July 2013 From 11am (AEST) today, Friday 12 July Inabox Group Limited (“Inabox”) shares will be tradable on the Australian Securities Exchange (ASX) under the ticker code IAB. Despite challenging market conditions the Company’s offer was oversubscribed. It raised $3.5 million, the maximum permissible under the terms of the offer. “Unfortunately we had to scale […]

Inabox Group Limited (‘IAB’ or ‘Inabox’) is pleased to confirm that M2 Telecommunications Group Ltd (‘M2’, ASX: MTU) has invested $2 million in Inabox under the terms of the Inabox Prospectus released in May 2013. M2’s investment of 1,666,667 shares at $1.20 per share will provide M2 with a stake of around 12 per cent […]

PERTH, AUSTRALIA: 4 July 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today that it will receive a Linkage Grant from the Australian Research Council (ARC) to collaborate with scientists at The University of Queensland’s Institute for Molecular Bioscience (IMB). The grant, which The University of Queensland […]